FTC Brings First-ever Action Targeting “iV Cocktail” Therapy Marketer

The Federal Trade Commission today, for the first time, charged a marketer and seller of intravenously injected therapy products (iV Cocktails) with making a range of deceptive and unsupported health claims about their ability to treat serious diseases such as cancer, multiple sclerosis, and congestive heart failure. The proposed FTC order settling the charges prohibits […]